Dr. V Venkata Sampath

MBBS, MD - Radiotherapy, DM - Oncology Medical Oncologist, Radiation Oncologist, Hematologic Oncologist Hyderabad

Hyderabad

Having following clinical research experience: 1. Phase III, Inoperable Gastric Cancer, Sub-Investigator, SVIMS/2011 2. Completed 20 Case Studies at time of MD & DM in NIMS & SVIMS 3. A Prospective, multicenter, randomised, double-blinded, 2-parallel groups, phase 3 study to compare as first-line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed by second line treatment by masitinib in combination with FOLFIRI 3 versus placebo in combination with FOLFIRI 3 in the treatment of patients with nonresectable locally advanced or metastatic pancreatic cancer. 4. A prospective multicenter, randomized, double-blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (Irinotecan, 5-fluorouracil, and folinic acid) to placebo in combination with FOLFIRI in second-line treatment of patients with metastatic colorectal cancer Experience in dealing with: Haematological malignancies, Lung cancer, Breast cancer, Ovarian cancer, HCC, RCC, Prostate cancer, Gastric cancer, Pancreas cancer, Colon cancer, Cervix cancer, GTN, Uterine cancer, Germ cell tumors, CNS tumors, Head & Neck cancers, Paediatric malignancies, Cancer biology, Biostatistics, Cytogenetics, Stem cell transplantation, Molecular & cell biology, Genomics etc.